Enter assignee name

CIPO Patents = 8

EPO Patents = 6

Forward Citations = 156

Loading Chart...

3 inventors (with patents filed for the assignee):

Neil Madison Cowen (13 out of 19 patents)

Khaled A Yamout (6 out of 7 patents)

Kenneth B Kashkin (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 12419895 - Methods for treating subjects with Prader-Willi syndrome (2025-09-23),

2. 12343348 - Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome (2025-07-01),

3. 12178823 - Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome (2024-12-31),

4. 11786536 - Salts of potassium ATP channel openers and uses thereof (2023-10-17),

5. 11045478 - Salts of potassium ATP channel openers and uses thereof (2021-06-29),

6. 10456408 - Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome (2019-10-29),

7. 10085998 - Salts of potassium ATP channel openers and uses thereof (2018-10-02),

8. 10058557 - Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome (2018-08-28),

9. 9782416 - Pharmaceutical formulations of potassium ATP channel openers and uses thereof (2017-10-10),

10. 9757384 - Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome (2017-09-12),

11. 9381202 - Salts of potassium ATP channel openers and uses thereof (2016-07-05),

12. 7799777 - Salts of potassium ATP channel openers and uses thereof (2010-09-21),

13. 7572789 - Salts of potassium ATP channel openers and uses thereof (2009-08-11),

Essentialis, Inc. is a biopharmaceutical company dedicated to developing breakthrough therapies for patients with rare metabolic diseases. With a focus on developing small molecule drugs, Essentialis is committed to improving the lives of those affected by these conditions. Through innovative research and strategic partnerships, Essentialis aims to bring life-changing treatments to market quickly and efficiently.

Profile summary based on public USPTO records.